Genedrive plc (GDR) Ordinary 1.5p Shares
- Add to watchlist
- Create an alert
- This stock can be held in a
2.45p
2.49p
12.10p
£13.04 million
2.45p
2.35p
1.43p
n/a
0.05p (2.08%) Previous:
0.05p
2,767,252
n/a
50,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 30/06/2023 | 30/06/2022 |
---|---|---|
Revenue (£m) | 0.06 | 0.05 |
Profit before tax (£m) | (5.98) | (5.63) |
Adjusted EPS (p): | (5.50) | 5.50 |
P/E ratio | n/a | 3.20 |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Director dealings: Genedrive chairman snaps up shares
15 August 2024 15:15
-
Genedrive makes first commercial sales of CYP2C19-ID testing kit
12 August 2024 09:01
-
Genedrive test ordered by five Manchester area hospitals
24 May 2024 12:24
-
Notice of Results
22 November 2024 07:00
-
NIHR and OLS Funding Package
21 November 2024 11:06
-
Scottish Health Technology Group publications
4 November 2024 13:29
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.